Non-Invasive Prenatal Testing (NIPT) is a groundbreaking approach to screening for genetic conditions in a fetus, using a simple blood test from the mother.
It analyzes small fragments of fetal DNA in the mother's bloodstream to detect chromosomal abnormalities and specific genetic disorders. A recent innovation in NIPT is the Vistara Single-Gene NIPT, which companies like Natera offer.
NIPT is a non-invasive screening test typically performed as early as 10 weeks into pregnancy. It’s a safer alternative to invasive procedures like amniocentesis, and its primary use is to detect: Trisomy 21 (Down syndrome), Trisomy 18, Trisomy 13, and Sex chromosome aneuploidies (e.g., Turner syndrome). While traditional NIPT focuses on chromosomal abnormalities, the Vistara Single-Gene NIPT goes further by screening for single-gene disorders.
Vistara NIPT screens for over 25 single-gene disorders, including Noonan syndrome, Achondroplasia, Cystic Fibrosis, Thanatophoric Dysplasia, Osteogenesis Imperfecta. These conditions are often severe, leading to developmental delays, physical abnormalities, or other significant health issues.
Panorama NIPT, also by Natera, focuses on chromosomal abnormalities such as trisomies and sex chromosome aneuploidies, while Vistara digs deeper into single-gene mutations. Panorama NIPT is ideal for parents primarily concerned with trisomies (like Down syndrome). Vistara NIPT is designed for those looking for a broader range of genetic conditions, especially rare single-gene disorders.
Natera Vistara List of Conditions Here’s a brief overview of some conditions included in the Natera Vistara list:Noonan syndrome: A genetic disorder causing abnormal growth and development.Achondroplasia: The most common type of dwarfism. Osteogenesis Imperfecta: is known as brittle bone disease, leading to fragile bones.Cystic Fibrosis: Affects the respiratory and digestive systems.Thanatophoric Dysplasia: A severe skeletal disorder causing life-threatening abnormalities. Natera provides detailed brochures and consultation services for a complete list of conditions.
The process for taking the NIPT test is straightforward: Blood sample collection from the mother, as early as 10 weeks into pregnancy. The sample is analyzed in the lab, and results are typically available within 7-10 days. Natera NIPT results will indicate the risk of the fetus having specific genetic conditions based on the DNA fragments found in the mother’s blood. Most results come back as either low risk or high risk, with further diagnostic tests (like amniocentesis) suggested for high-risk findings.
At Diagnopein Diagnostics, we prioritize accuracy, patient comfort, and fast turnaround times for NIPT testing, including advanced options like Vistara NIPT. Here’s why you should choose us:
A) Accurate Results: We partner with leading laboratories like Natera to provide precise and reliable test results.
B) Advanced Technology: Diagnopein ‘s facilities are equipped with modernized technology to ensure comprehensive genetic screening.
C) Experienced Staff: Our team of specialists ensures that you receive the best prenatal care and support.
D) Affordable Pricing: At Diagnopein in Pune, we strive to offer competitive rates and collaborate with insurance providers to minimize out-of-pocket costs.
E) Comprehensive Care: From pre-test counseling to post-result follow-ups, we are with you every step of the way.
You can take the Vistara NIPT as early as 10 weeks into pregnancy.
Vistara screens for single-gene disorders, while Panorama focuses on chromosomal abnormalities like Down syndrome.
Many insurance plans cover NIPT, but coverage for single-gene testing like Vistara may vary. It’s best to check with your provider.
You can expect results within 7-10 business days after the test.
Yes, NIPT is a non-invasive test and poses no risk to the baby or the mother.
